$2.01
4.69% yesterday
Nasdaq, Aug 12, 10:09 pm CET
ISIN
US34960Q1094
Symbol
FBIO

Fortress Biotech, Inc. Stock price

$2.01
+0.05 2.55% 1M
+0.28 16.19% 6M
-0.02 0.74% YTD
+0.24 13.56% 1Y
-17.04 89.45% 3Y
-42.54 95.49% 5Y
-45.84 95.80% 10Y
-147.99 98.66% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+0.09 4.69%
ISIN
US34960Q1094
Symbol
FBIO
Industry

Key metrics

Basic
Market capitalization
$56.8m
Enterprise Value
$23.7m
Net debt
positive
Cash
$91.3m
Shares outstanding
29.6m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.0 | 0.6
EV/Sales
0.4 | 0.3
EV/FCF
negative
P/B
2.6
Financial Health
Equity Ratio
15.8%
Return on Equity
-245.8%
ROCE
-92.0%
ROIC
-221.2%
Debt/Equity
2.6
Financials (TTM | estimate)
Revenue
$57.8m | $87.4m
EBITDA
$-91.6m | $-42.8m
EBIT
$-96.0m | $-64.0m
Net Income
$-50.8m | $-42.2m
Free Cash Flow
$-74.4m
Growth (TTM | estimate)
Revenue
-32.1% | 51.6%
EBITDA
18.0% | 60.3%
EBIT
17.9% | 42.5%
Net Income
19.4% | 24.5%
Free Cash Flow
32.6%
Margin (TTM | estimate)
Gross
67.4%
EBITDA
-158.4% | -49.0%
EBIT
-166.2%
Net
-87.8% | -48.3%
Free Cash Flow
-128.7%
More
EPS
$-1.9
FCF per Share
$-2.5
Short interest
13.4%
Employees
101
Rev per Employee
$570.0k
Show more

Is Fortress Biotech, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Fortress Biotech, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Fortress Biotech, Inc. forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Fortress Biotech, Inc. forecast:

Buy
88%
Hold
13%

Financial data from Fortress Biotech, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
58 58
32% 32%
100%
- Direct Costs 19 19
30% 30%
33%
39 39
33% 33%
67%
- Selling and Administrative Expenses 95 95
14% 14%
165%
- Research and Development Expense 36 36
61% 61%
62%
-92 -92
18% 18%
-158%
- Depreciation and Amortization 4.49 4.49
15% 15%
8%
EBIT (Operating Income) EBIT -96 -96
18% 18%
-166%
Net Profit -51 -51
19% 19%
-88%

In millions USD.

Don't miss a Thing! We will send you all news about Fortress Biotech, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fortress Biotech, Inc. Stock News

Neutral
GlobeNewsWire
about 7 hours ago
S econd quarter 2025 revenues were $15.0 million Emrosi™ net sales of $2.8 million generated in first full quarter on the market The Company joined the Russell 2000® and Russell 3000® Indexes in June 2025 Company to hold conference call today at 4:30 p.m. ET to discuss the financial results and provide a business update SCOTTSDALE, Ariz.
Neutral
GlobeNewsWire
6 days ago
SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”, “we”, or “our”), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that ...
Neutral
GlobeNewsWire
7 days ago
Company to host conference call to discuss financial results and provide a corporate update on August 12, 2025 at 4:30 p.m. ET Company to host conference call to discuss financial results and provide a corporate update on August 12, 2025 at 4:30 p.m. ET
More Fortress Biotech, Inc. News

Company Profile

Fortress Biotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel pharmaceutical and biotechnology products. It operates through the following segments: Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development. The company was founded on June 28, 2006 and is headquartered in New York, NY.

Head office United States
CEO Lindsay Rosenwald
Employees 101
Founded 2006
Website www.fortressbiotech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today